Clinical Development

Australia continues to remain at the forefront for conducting human clinical trials intended for inclusion in marketing applications worldwide. Australia is home to some of the worlds best researchers and health professionals and boasts a world-class research infrastructure, a stable socio-political environment, and high standards that ensure confidence in the scientific conclusions reached by clinical trials conducted in Australia. With the possible access to the Australian governments generous Research and Development Tax Incentive, the costs for conducting studies in Australia are also cost-effective.

Accelagen clinical research team have directly managed the delivery of high quality clinical trial outcomes for both medicines and device throughout all phases of development, from Phase I first in human trials, to Phase IV post-marketing intervention and safety studies. Our depth of experienced gained by the team members covers a wide range of therapeutic areas, including:

  • Anaesthesia
  • Analgesia
  • Cardiovascular
  • Gastroenterology
  • Haematology
  • Hepatology
  • Immunology
  • Neurology
  • Oncology
  • Orthopaedics
  • Psychiatry
  • Rare diseases
  • Renal
  • Respiratory
  • Rheumatology
  • Transplant
  • Urology